MEDIBANK PRIVATE LIMITED (MPL)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

MPL

MPL - MEDIBANK PRIVATE LIMITED

FNArena Sector : Insurance
Year End: June
GICS Industry Group : Insurance
Debt/EBITDA: N/A
Index: ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS

Medibank Private is the largest Australian private health insurance provider. Previously an Australian Government business enterprise, established by the Whitlam government in 1975, it was privatised in 2014.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$5.02

28 Aug
2025

-0.130

OPEN

$5.19

-2.52%

HIGH

$5.19

12,394,648

LOW

$4.83

TARGET
$5.087

+0.05 change from previous day

 1.3% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AUB . CVW . FCL . GDG . HLI . IAG . NHF . NOL . QBE . SDF . SUN . TWR .
FNARENA'S MARKET CONSENSUS FORECASTS
MPL: 1
Title FY24
Actual		 FY25
Actual		 FY26
Forecast		 FY27
Forecast
EPS (cps) xxx 18.2 23.3 xxx
DPS (cps) xxx 18.0 18.6 xxx
EPS Growth xxx 1.7% 28.1% xxx
DPS Growth xxx 8.4% 3.4% xxx
PE Ratio xxx N/A 21.9 xxx
Dividend Yield xxx N/A 3.7% xxx
Div Pay Ratio(%) xxx 99.0% 80.0% xxx

Dividend yield today if purchased 3 years ago: 4.79%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 3.53

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 04/09 - ex-div 9.4c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx18.2
DPS All xxxxxxxxxxxxxxx18.0
Sales/Revenue xxxxxxxxxxxxxxx8,532.8 M
Book Value Per Share xxxxxxxxxxxxxxx84.8
Net Operating Cash Flow xxxxxxxxxxxxxxx514.1 M
Net Profit Margin xxxxxxxxxxxxxxx5.87 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx21.58 %
Return on Invested Capital xxxxxxxxxxxxxxx20.28 %
Return on Assets xxxxxxxxxxxxxxx10.67 %
Return on Equity xxxxxxxxxxxxxxx21.58 %
Return on Total Capital xxxxxxxxxxxxxxx29.63 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx29.2 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx64 M
Long Term Debt xxxxxxxxxxxxxxx145 M
Total Debt xxxxxxxxxxxxxxx209 M
Goodwill - Gross xxxxxxxxxxxxxxx421 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx649 M
Price To Book Value xxxxxxxxxxxxxxx5.95

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx69.8 M
Capex % of Sales xxxxxxxxxxxxxxx0.82 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx471 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx3,082 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.2

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

29/08/2025

1

Overweight

$5.55

10.56%

Medibank Private reported underlying NPAT which was 1% above Morgan Stanley's forecast but below consensus by -1%. Total health insurance margin was in line at 9% and resident claims growth per policy at 2.2% was below the forecast of 2.3%.

Health insurance resident gross margin of 16.2% was in line, with non-resident gross margin better at 36.9%.

Morgan Stanley believes the FY26 guidance for margins is conservative, and there are improved policyholder growth prospects with a robust balance sheet for further growth.

Overweight. Target slips to $5.55 from $5.57. Industry View: In-Line.

FORECAST
Morgan Stanley forecasts a full year FY26 dividend of 19.10 cents and EPS of 23.00 cents.
Morgan Stanley forecasts a full year FY27 dividend of 20.20 cents and EPS of 25.00 cents.

Ord Minnett

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

4

xxxxxxxxx xx xxxx xxxx xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

07/07/2025

3

Neutral

$4.65

-7.37%

Jarden marked-to-market investment movements for insurance and wealth stocks for the June quarter, noting a fall in risk-free rates, a strong rebound in global equities, USD depreciation and credit spread compression.

The broker highlights the stronger equity market provides EPS support for FY25 for private health insurers.

EPS forecast for Medibank Private lifted by 2.5% for FY25 but trimmed by -0.5% for FY26.

Neutral. Target rises to $4.65 from $4.45.

FORECAST
Jarden forecasts a full year FY26 dividend of 18.70 cents and EPS of 23.00 cents.
Access Extra Coverage Research History >

MPL STOCK CHART

FNArena News on MPL

1
FNArena Corporate Results Monitor – 29-08-2025

Aug 29 2025 - Australia
2
Rudi’s View: BlueScope Steel, IGO, GrainCorp, Pilbara Minerals, Santos & More

Aug 14 2025 - Rudi's View
3
Rudi’s View: AI Updates, Hot Favourites & First August Results

Aug 07 2025 - Rudi's View
4
Rudi’s View: Bega Cheese, Cettire, Harvey Norman, Sigma, SiteMinder & More

Jul 24 2025 - Rudi's View
5
Rudi’s View: Aussie Broadband, oOh!media, Paladin Energy, Seek, Xero & More

Jul 17 2025 - Rudi's View

Latest Insurance News

1
Insurers To Pamper Shareholders With Buybacks

Jan 24 2025 - Australia
2
IAG Shares Breaking Out

Jan 21 2025 - Technicals
3
ESG Focus: The Little Big Things – 21-11-2024

Nov 21 2024 - ESG Focus
4
New-Look Suncorp Ready To Rumble

Nov 14 2024 - Australia
5
Steadfast’s Long March

Jul 02 2024 - Australia
6
AUB Group Shares Poised For Break-Out

Jun 13 2024 - Technicals
7
SMSFundamentals: Older People Are Life Insurers’ Future Challenge

Oct 26 2023 - SMSFundamentals
8
Australian Insurers And The Weather

Oct 19 2023 - Feature Stories
9
Steadfast Group’s US Entry Full Of Promise

Oct 11 2023 - Australia
10
Pros And Cons Of Insurance Companies

Aug 02 2023 - Australia